Is monoclonal antibody therapy effective and achievable in hospitals with limited resources?

Dr Nikhitha Mantri researched the use of MAT treatments for COVID-19 patients with mild to moderate symptoms at an inner-city hospital with limited resources in the Bronx

Monoclonal antibody therapy (MAT) is a way of treating COVID-19 for people who have tested positive, have mild to moderate symptoms, and are at high risk of developing more serious symptoms and complications. Although there are already studies showing promising results, the number of patients in the US, especially ethnic minorities, who have so far received MAT is small. Dr […]

Read More… from Is monoclonal antibody therapy effective and achievable in hospitals with limited resources?